Pharmaceutical

Causaly secures $60 Million in series B funding

Causaly serves 12 of the top 20 pharmaceutical companies with technology that aims to expedite the drug discovery process.

Jul 15, 2023 - 20:00
Causaly secures $60 Million in series B funding
Causaly serves 12 of the top 20 pharmaceutical companies with technology that aims to expedite the drug discovery process.
Read the original article

Tags:

Previous Article

Bicycle Therapeutics plans $200m public offering

Next Article

Coherus plans Humira biosimilar sale at 85% discount

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Nearly half of U.S. adults would spend $100 a month for weight loss drugs; Pfizer scraps an obesity pill

STAT+: Pharmalittle: Nearly half of U.S. adults would s...

Jun 26, 2023

For pharma companies, the possibilities of green chemistry are huge

For pharma companies, the possibilities of green chemis...

Nov 1, 2024

STAT+: European regulators consider appeal over Amylyx ALS drug

STAT+: European regulators consider appeal over Amylyx ...

Oct 12, 2023